JP2021515019A5 - - Google Patents

Info

Publication number
JP2021515019A5
JP2021515019A5 JP2020546886A JP2020546886A JP2021515019A5 JP 2021515019 A5 JP2021515019 A5 JP 2021515019A5 JP 2020546886 A JP2020546886 A JP 2020546886A JP 2020546886 A JP2020546886 A JP 2020546886A JP 2021515019 A5 JP2021515019 A5 JP 2021515019A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
propyl
substituted
haloalkoxy
Prior art date
Application number
JP2020546886A
Other languages
English (en)
Japanese (ja)
Other versions
JP7405756B2 (ja
JP2021515019A (ja
JPWO2019170115A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/077249 external-priority patent/WO2019170115A1/en
Publication of JP2021515019A publication Critical patent/JP2021515019A/ja
Publication of JPWO2019170115A5 publication Critical patent/JPWO2019170115A5/ja
Publication of JP2021515019A5 publication Critical patent/JP2021515019A5/ja
Application granted granted Critical
Publication of JP7405756B2 publication Critical patent/JP7405756B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020546886A 2018-03-08 2019-03-07 ピロリジンアミド誘導体及びその使用 Active JP7405756B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810192198 2018-03-08
CN201810192198.6 2018-03-08
PCT/CN2019/077249 WO2019170115A1 (en) 2018-03-08 2019-03-07 Pyrrolidineamide derivatives and uses thereof

Publications (4)

Publication Number Publication Date
JP2021515019A JP2021515019A (ja) 2021-06-17
JPWO2019170115A5 JPWO2019170115A5 (https=) 2022-02-01
JP2021515019A5 true JP2021515019A5 (https=) 2022-02-01
JP7405756B2 JP7405756B2 (ja) 2023-12-26

Family

ID=67845842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020546886A Active JP7405756B2 (ja) 2018-03-08 2019-03-07 ピロリジンアミド誘導体及びその使用

Country Status (8)

Country Link
US (1) US11225460B2 (https=)
EP (1) EP3762364B1 (https=)
JP (1) JP7405756B2 (https=)
CN (1) CN110240557B (https=)
AU (1) AU2019230883B2 (https=)
CA (1) CA3092747A1 (https=)
SG (1) SG11202008543RA (https=)
WO (1) WO2019170115A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240317681A1 (en) * 2020-07-07 2024-09-26 Sunshine Lake Pharma Co., Ltd. Pyrrolidine amide derivative salt and use thereof
CN113896671B (zh) * 2020-07-07 2023-06-09 广东东阳光药业有限公司 吡咯烷酰胺衍生物的盐及其用途
CN113896670B (zh) * 2020-07-07 2023-06-09 广东东阳光药业有限公司 吡咯烷酰胺衍生物的盐及其用途
CN114573491B (zh) * 2020-12-01 2023-12-08 广东东阳光药业股份有限公司 吡咯烷酰胺衍生物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94466A (en) 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
WO2000033788A2 (en) 1998-12-11 2000-06-15 American Biogenetic Sciences Inc. Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
FR2799461B1 (fr) 1999-10-11 2002-01-04 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
MY134480A (en) * 2002-09-20 2007-12-31 Hoffmann La Roche 4-pyrrolidino-phenyl-benzyl ether derivatives
EP1524265A1 (en) * 2003-10-15 2005-04-20 Newron Pharmaceuticals S.p.A. Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors
WO2006013049A2 (en) * 2004-08-02 2006-02-09 F.Hoffmann-La Roche Ag Benzyloxy derivatives as maob inhibitors
US7501528B2 (en) 2005-03-15 2009-03-10 Hoffmann-La Roche Inc. Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives
US20070078172A1 (en) 2005-06-16 2007-04-05 Jenrin Discovery Mao-b inhibitors useful for treating obesity
BRPI0821026A2 (pt) 2007-12-19 2015-06-16 Newron Pharmaceutical S P A Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
CA2886904A1 (en) * 2012-10-02 2014-04-10 Cyril Montagne Pyrrolidines
EP3601255A1 (en) 2017-03-21 2020-02-05 AbbVie Deutschland GmbH & Co. KG Proline amide compounds and their azetidine analogues carrying a specifically substituted benzyl radical

Similar Documents

Publication Publication Date Title
JP2021515019A5 (https=)
JP2019505541A5 (https=)
JP2021536433A5 (https=)
MX2020002060A (es) Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos.
JP2011513305A5 (https=)
SA518391518B1 (ar) مشتقات n-] 2-(1- بنزيل ببريدين-4-يل) إيثيل[ -4-(بيرازين-2-يل)-ببرازين-1- كربوكساميد ومركبات متصلة بها كمضادات مستقبلة المسكارين 4 (m4) لمعالجة أمراض عصبية
RU2011139893A (ru) Фунгицидные пиразолы
JP2017501237A5 (https=)
JP2017504635A5 (https=)
JP2012041349A5 (https=)
JP2015531773A5 (https=)
JP2007538094A5 (https=)
JP2016532715A5 (https=)
GB0402653D0 (en) Compounds
JP2015537020A5 (https=)
JP2013056919A5 (https=)
BRPI0821746A2 (pt) Composto, uso do mesmo, composição, semente, método para controlar fungos fitopatogênicos, medicamento, e, processos para preparar um antimicótico e para preparar compostos
BRPI0821362A2 (pt) Composto, uso do mesmo, composição, semente, método para controlar fungos fitopatogênicos, medicamento, e, processos para preparar um antimicótico e para preparar compostos
WO2012099942A3 (en) Methods and compositions for treating metabolic syndrome
JP2019518764A5 (https=)
RU2015147450A (ru) ПРОИЗВОДНЫЕ 2-ФЕНИЛ ИЛИ 2-ГЕТЕРОАРИЛ ИМИДАЗОЛ[1,2-a]ПИРИДИНА
JP2017537937A5 (https=)
JP2015535847A5 (https=)
MX2021007800A (es) Composiciones y metodos para usar 2-(4-clorofenil)-n-((2-(2,6-diox opiperidin-3-il)-1-ox-oisoindolin-5il)metil)-2,2-difluoroacetamid a.
JP2018527324A5 (https=)